WAKAMOTO PHARMACEUTICAL CO.,LTD.JP:4512Balance sheet

Market cap
¥10.4B
P/E ratio
51.9x
2014/032015/032016/032017/032018/032019/032020/032021/032022/032023/032024/032025/03
Cash and cash equivalents -2,5722,5213,6113,8493,2622,8842,8443,2323,8793,6652,955
Marketable securities, current -406407---------
Inventories-1,2681,7451,5301,2951,3801,4111,0671,2509901,0311,964
Total current assets-9,6869,5599,7899,8999,6258,6487,6388,6089,3538,9708,908
Property, plant and equipment, net-5,0624,7644,2244,0593,9073,6483,5273,2973,0323,0283,313
Marketable securities, non-current -2,8642,7222,5952,8252,6342,4112,4662,0662,4832,4421,848
Total non-current assets-9,2858,7248,0998,0568,1397,3356,9346,3456,3586,4516,094
Total assets -18,97118,28317,88817,95517,76415,98314,57214,95315,71215,42115,003
Short-term debt-308428260260140100100100100100100
Total current liabilities-2,6672,5712,4672,4142,7092,4351,7132,0092,2391,8082,035
Long-term debt, non-current -68836020040-------
Total non-current liabilities-2,1801,7581,5251,4331,2941,6021,4741,4641,5661,5871,358
Total liabilities -4,8474,3293,9923,8484,0034,0363,1873,4733,8053,3953,392
Common stock and paid-in capital -6,0726,0726,0726,0726,0726,0726,0726,0726,0726,0726,072
Retained earnings-6,9536,8696,8606,8826,5964,9404,3384,5684,7064,7114,672
Stockholders' equity13,81314,12413,95513,89714,10713,76111,94711,38611,48111,90712,02611,610